Author

B. C. Sheppard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

C. D. Lopez· 2 shared G. B. Mills· 2 shared A. Gower· 1 shared A. Grossblatt-Wait· 1 shared A. Guimaraes· 1 shared A. H. Skalet· 1 shared A. Kardosh· 1 shared A. L. Creason· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. D. Lopez

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Ongoing Replication Stress Response and New Clonal T Cell Development Discriminate Between Liver and Lung Recurrence Sites and Patient Outcomes in Pancreatic Ductal Adenocarcinoma

J. M. Link, C. Pelz, P. J. Worth, S. Owen, D. Keith, E. M. Langer, A. Grossblatt-Wait, A. L. Creason, J. Egger, H. Holly, I. English, K. MacPherson, M. Tsuda, J. Goecks, E. Demir, , R. C. Sears

This study identifies transcriptomic and immune features distinguishing liver and lung metastatic sites in PDAC, linking replication stress response and T cell clonal development to patient outcomes.

bioRxiv · May 4, 2022 · PreprintCancer Biology

Relevance of Circulating Hybrid Cells as a Non-Invasive Biomarker for Myriad Solid Tumors

M. S. Dietz, T. L. Sutton, B. S. Walker, C. E. Gast, L. Zarour, S. K. Sengupta, J. R. Swain, J. Eng, M. Parappilly, K. Limbach, A. Sattler, E. Burlingame, Y. Chin, A. Gower, J. L. Montoya Mira, , M. H. Wong

This study identifies circulating hybrid cells (CHCs) as a novel biomarker for metastatic solid tumors, showing they outnumber CTCs and exhibit tumor-initiating properties across multiple cancer types.

bioRxiv · Mar 11, 2021 · PreprintCancer Biology